Post-Transplant Complications
Bone Marrow Transplantation (2004) 34, 491–496. doi:10.1038/sj.bmt.1704618 Published online 2 August 2004
Bone metabolism in patients more than five years after bone marrow transplantation
K Kerschan-Schindl1, M Mitterbauer2, W Füreder2, S Kudlacek3, S Grampp4, C Bieglmayer5, V Fialka-Moser1, P Pietschmann6,7 and P Kalhs2,7
- 1Department of Physical Medicine and Rehabilitation, University of Vienna, Vienna, Austria
- 2Department of Internal Medicine I, University of Vienna, Vienna, Austria
- 3Hospital Barmherzige Brueder, Vienna, Austria
- 4Department of Radiology, Osteology, University of Vienna, Vienna, Austria
- 5Department of Biochemistry, University of Vienna, Vienna, Austria
- 6Department of Pathophysiology, University of Vienna, Vienna, Austria
Correspondence: Dr P Pietschmann, Department of Pathophysiology, Waehringer Guertel 18-20, 1090 Vienna, Austria. E-mail: Peter.Pietschmann@akh-wien.ac.at
7Both authors contributed equally to the paper and deserve to be ranked as senior authors.
Received 19 January 2004; Accepted 3 May 2004; Published online 2 August 2004.
Abstract
We investigated the bone metabolism of 22 patients (median age 38 years) over 6 years after allogeneic bone marrow transplantation (BMT). Biplanar roentgenograms of the thoracic and lumbar spine were used to diagnose vertebral deformities caused by fractures. The actual bone mineral density (BMD) of the lumbar spine and the femoral neck were measured. Laboratory tests included calcium, phosphate, parathyroid hormone, a marker of bone resorption (beta-crosslaps, CTX), markers of bone formation (osteocalcin, bone-specific alkaline phosphatase), osteoprotegerin (OPG) – an antagonist of the osteoclast differentiation factor RANKL, and sex hormone status. One patient had a vertebral fracture. Seven patients (28%) had osteopenia in the lumbar spine while 12 patients (48%) had osteopenia in the femoral neck. Bone resorption was increased in nine patients (43%) and bone formation was increased in four patients (20%). BMT recipients had significantly increased serum levels of OPG (P=0.029). Three women (75%) and four men (25%) were hypogonadal. The data showed that BMD is reduced and bone metabolism is still disturbed more than 6 years after BMT. The RANKL/osteoprotegerin system appears to play an important role in the pathophysiology of late post transplantation osteoporosis.
Keywords:
allogeneic bone marrow transplantation, bone metabolism, osteoprotegerin
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Drug Insight: existing and emerging therapies for osteoporosis
Nature Clinical Practice Endocrinology & Metabolism Review (01 Dec 2006)
RESEARCH
Bone Marrow Transplantation Original Article
Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects
Bone Marrow Transplantation Original Article
Bone Marrow Transplantation Original Article
Kidney International Original Article

